US 9526769
Macrocylic oximyl hepatitis C protease inhibitors
granted A61KA61K38/21A61K38/212
Quick answer
US patent 9526769 (Macrocylic oximyl hepatitis C protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K38/21, A61K38/212, A61K38/215, A61K38/45